Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006879 |
YEM_ID: | YEM-926 |
ID: | TCMBANKHE006879/YEM-926 |
植物拉丁名: |
|
功能与主治: | To clear heat and resolve toxin, dispel stasis and relieve pain./Cough, throat pain, knocks and falls, toothache. |
药用植物名: | 文殊兰 |
药名: | 文殊兰 |
来源: | 云南民族药物志：第五卷 |
药用部位: | root and bulb |
使用民族: | 傣族/哈尼族/苗族/瑶族/壮族 |
TCM_ID_id: | 6129 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000713 | Columbin | 546-97-4; Tinosporin; columbin; C09077 | C20H22O6 | 358.39 | CC12CCC3C(=O)OC(CC3(C1C4C=CC2(C(=O)O4)O)C)C5=COC=C5 |
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN001121 | latifoliumidrine | ||||
| TCMBANKIN001946 | 3- methyl- 1H- pyrimidine- 2,4- dione | 3-methyl-1H-pyrimidine-2,4-dione | C5H6N2O2 | 126.11 g/mol | CN1C(=O)C=CNC1=O |
| TCMBANKIN004485 | lycorenan- 7-one | lycorenan-7-one | |||
| TCMBANKIN005404 | Hippeastrine | BPBio1_000847; STOCK1N-52692; BSPBio_000769; NSC731436; Lycorenan-7-one, 5-hydroxy-1-methyl-9,10-(methylenebis(oxy))-, (5alpha)-; 30803-79-3; hippeastrine; C08528; 477-17-8; Prestwick3_000675 | C17H17NO5 | 315.32 | CN1CCC2=CC(C3C(C21)C4=CC5=C(C=C4C(=O)O3)OCO5)O |
| TCMBANKIN008153 | Nonadecanoic acid ethyl ester | C21H42O2 | 326.6 g/mol | CCCCCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN008568 | tadehaginoside | C21H22O10 | C1=CC(=CC=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=CC(=CC(=C3)O)O)O)O)O)O | ||
| TCMBANKIN009041 | Ethyl oleate | 9-Octadecenoic acid (Z)-, ethyl ester; 9-Octadecenoic acid, (Z)-, ethyl ester; NSC 229428; 9-Octadecenoic acid, ethyl ester, (E)-; EINECS 203-889-5; Ethyl cis-9-octadecenoate; 9-OCTADECENOIC ACID ETHYL ESTER (Z); FEMA No. 2450; EINECS 228-082-5; octadec-9-enoic acid ethyl ester; Oleic acid, ethyl ester; 9-Octadecenoic acid (9Z)-, ethyl ester; Ethyl elaidate; ST5410316; ethyl (E)-octadec-9-enoate; (E)-octadec-9-enoic acid ethyl ester; ethyl oleate; 111-62-6; AI3-00657; 6114-18-7; Ethyl oleate (natural); Ethyl (9E)-9-octadecenoate; Elaidic acid ethyl ester; NSC229428; ethyl octadec-9-enoate; Ethyl 9-octadecenoate, (Z)-; (E)-9-Octadecenoic acid ethyl ester; E8377_SIGMA; 9-Octadecenoic acid, ethyl ester; Oleic acid, ethyl ester (6CI,8CI) | C20H38O2 | 310.51 | CCCCCCCCC=CCCCCCCCC(=O)OCC |
| TCMBANKIN009560 | lycoramine | C17H23NO3 | 289.37 | CN1CCC23CCC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br | |
| TCMBANKIN010138 | latiphenanthdrine | ||||
| TCMBANKIN010568 | lycoxanthin | C40H56O | 552.9 g/mol | CC(=CCCC(=CC=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)CO)C)C)C)C | |
| TCMBANKIN012433 | Pyrmidine-2,4- diol | Pyrmidine-2,4-diol | |||
| TCMBANKIN013900 | Arolyconricidine | ||||
| TCMBANKIN014354 | 6-hydroxy-eudesm-4(14)-ene | ||||
| TCMBANKIN014770 | 5-methyl-2-hexanonc | ||||
| TCMBANKIN014847 | Lycorenan | C15H17NO | 227.3 g/mol | C1CNC2C1=CCC3C2C4=CC=CC=C4CO3 | |
| TCMBANKIN015332 | lycorenium B | ||||
| TCMBANKIN016253 | 5＇-O-nitrosouridine | 5 ＇- O- nitrosouridine | |||
| TCMBANKIN016571 | Latifoliumdine | ||||
| TCMBANKIN017221 | linoleic acid | (9E,12E)-octadeca-9,12-dienoate; AC1NYW3V; sodium (9E,12E)-octadeca-9,12-dienoate; BDBM22336; 9,12-octadecadienoate; linoleicacid | C18H31O2- | 279.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)[O-] |
| TCMBANKIN017351 | lycoridine | ||||
| TCMBANKIN017734 | latifoliumpurine | ||||
| TCMBANKIN017816 | tazettine | C18H21NO5 | 331.4 g/mol | CN1CC2(C3(C1CC(C=C3)OC)C4=CC5=C(C=C4CO2)OCO5)O | |
| TCMBANKIN018323 | Arolyeorieidin | ||||
| TCMBANKIN018400 | 1ycorenium A | C18H38I2N2O4 | C[N+](C)(C)CCOC(=O)CCCCCCC(=O)OCC[N+](C)(C)C.[I-].[I-] | ||
| TCMBANKIN019768 | Cinnamyl- D- glueopyranoside | Cinnamyl-D-glueopyranoside | |||
| TCMBANKIN019942 | vitamin e | vitamin-e; LS-187838; alpha-tocopherol; tocopherol; β-Tocopherol; α-tocopher | C29H50O2 | 430.7 g/mol | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C |
| TCMBANKIN020421 | Lyeorenan- 7- one | Lyeorenan-7-one | |||
| TCMBANKIN023727 | pseudolycorine | C7H6O3 | 138.12 | COC1=C(C=C2C3C(C(C=C4C3N(CC4)CC2=C1)O)O)O | |
| TCMBANKIN025300 | p- hydroxy- benzonicacid | p-hydroxy-benzonicacid | |||
| TCMBANKIN025333 | lyconrenan- 7- one | lyconrenan-7-one | |||
| TCMBANKIN025436 | N-Methyl- dendroblum | n-Methyl-dendroblum | |||
| TCMBANKIN025867 | Z- cinnalnie acid | Z-cinnalnieacid | |||
| TCMBANKIN025907 | crinasiatine | C22H17NO4 | 359.4 g/mol | C1C(OC2=C(O1)C=C3C4=CC=CC=C4NC(=O)C3=C2)CC5=CC=C(C=C5)O | |
| TCMBANKIN027604 | latifaliumin C | ||||
| TCMBANKIN028808 | latifoliumin A | C12H18O3 | CC(=O)C=CC1C2(CC(CC1(O2)C)O)C | ||
| TCMBANKIN030722 | Latifoliumprine | ||||
| TCMBANKIN031199 | latifoliumin B | ||||
| TCMBANKIN031266 | N- methyl- benzamide | N-methyl-benzamide | C8H9NO | 135.16 g/mol | CNC(=O)C1=CC=CC=C1 |
| TCMBANKIN031818 | Ergosta-5-en-3β-ol | ||||
| TCMBANKIN032756 | latifoliumin D | ||||
| TCMBANKIN032837 | latifoliumside | ||||
| TCMBANKIN033166 | latifoliumol | C20H26O3 | CC1COC2=C1C=C3C=CC4C(CCCC4(CC3=C2O)O)(C)C | ||
| TCMBANKIN033515 | narcielasine | ||||
| TCMBANKIN034113 | Arolycorieidine | ||||
| TCMBANKIN035193 | N- palmitic acid | n-palmitic acid; n-Palmiticacid | |||
| TCMBANKIN037440 | Uridine | URI; SBB000838; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione; SMR000058222; MLS000069625; AIDS185903; 1-beta-D-Ribofuranosyluracil; NSC 20256; 1-[(2R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE; SY005419; AKOS015960347; MolPort-005-932-481; AC-10519; araU; 12693-39-9; ZINC02583633; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; AB0012293; Uracil-1-beta-D-ribofuranoside; SCHEMBL890304; NCGC00142368-01; C00299; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; BG00950366; U3750_SIGMA; Uridine, labeled with tritium; AI3-52690; AIDS-185903; U3003_SIGMA; AS-12665; Uracil, 1-beta-D-ribofuranosyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidine-2,4-quinone; 21231-59-4; U6381_SIGMA; SMP1_000029; CHEBI:16704; 68184-15-6; 1-((2r,5r)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; EINECS 200-407-5 | 244.201 | ||
| TCMBANKIN043842 | Ungeremine | 266.27 g/mol | |||
| TCMBANKIN058306 | cinnamic acid | Cinnamic acid, (Z)-; trans-beta-Carboxystyrene; (Z)-3-phenylprop-2-enoate; Cinnamylic acid; trans-Zimtsaeure; Benzenepropenoic acid; Zimtsaeure; cinnamic acid ; 3-phenylprop-2-enoic acid; C80857_ALDRICH; 102-94-3; 133760_ALDRICH; AIDS-017619; tert-.beta.-Phenylacrylic acid; BRN 1905952; STK286093; InChI=1/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11; CCRIS 3190; NSC174025; 3-Phenylpropenoic acid; CHEBI:35700; W228818_ALDRICH; cinnamicacid; (E)-3-Phenyl-2-propenoic acid; 4-09-00-02002 (Beilstein Handbook Reference); NSC623441; AC1OAGPW; 140-10-3; Benzylideneacetic acid; NSC44010; Zimtsaeure [German]; 2-Propenoic acid, 3-phenyl-, (E)-; 3-Phenyl-2-propenoic acid; NSC9189; 2-Propenoic acid, 3-phenyl-, (Z)-; trans-3-Phenylacrylic acid; C10438; W228826_ALDRICH; Cinnamic acid, (E)-; WLN: QV1U1R; NCGC00165979-01; NSC 44010; CHEBI:27386; (2Z)-3-phenylacrylate; trans-Cinnamic acid; (Z)-Cinnamic acid; (2E)-3-phenylprop-2-enoic acid; Acidum cinnamylicum; (2E)-3-phenyl-2-propenoic acid; 621-82-9; cis-.beta.-Carboxystyrene; PHENYLETHYLENECARBOXYLIC ACID; EINECS 210-708-3; 2-Propenoic acid, 3-phenyl-; 3-Phenylacrylic acid; CHEBI:35697; EINECS 205-398-1; cis-Cinnamic acid; BRN 0507757; C00423; (2Z)-3-phenylprop-2-enoate; Kyselina skoricove [Czech]; Phenylacrylic acid; Cinnamic acid; Cinnamic acid (natural); (E)-3-phenylacrylic acid; cis-cinnamate; AI3-00891; (2E)-3-phenylacrylic acid; Allocinnamic acid; (E)-3-phenylprop-2-enoic acid; (E)-Cinnamic acid; beta-phenylacrylic acid; AIDS017619; trans-Cinnamate; trans-.beta.-Carboxystyrene; trans-3-Phenyl-2-propenoic acid; 96340_FLUKA; FEMA No. 2288; trans-3-Phenylpropensaeure; NSC 9189; Isocinnamic acid; AI3-23709; cis-Cinnamic acidanion; E-cinnamicacid; E-cinnamic acid; E- cinnamicacid; 3-Phenylpropenoic acid | C9H8O2 | 148.16 | C1=CC=C(C=C1)C=CC(=O)O |
| TCMBANKIN058358 | benzyl-D-glucopyranoside | benzyl- D- glucopyrano- side;4304-12-5; TimTec1_005150; Benzyl .beta.-D-glucopyranoside; AIDS-186169; benzyl glucopyranoside; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(phenylmethoxy)tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(phenylmethoxy)oxane-3,4,5-triol; AIDS186169; ACon1_002322; (2R,3R,4S,5S,6R)-2-(benzyloxy)-6-methylol-tetrahydropyran-3,4,5-triol;(2S,3S,4S,5S,6R)-2-(benzyloxy)-6-methylol-tetrahydropyran-3,4,5-triol; (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-(phenylmethoxy)tetrahydropyran-3,4,5-triol; ST5309395; B5782_SIGMA;Benzyl glucopyranoside;benzyl alcoholo-β-d-glucopyranoside;Benzyl alpha-D-mannopyranoside | C13H18O6 | 270.28 g/mol | C1=CC=C(C=C1)COC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN058549 | Lycorenium A | C16H12NO3+ | C1C[N+]2=CC3=CC4=C(C=C3C5=CC(=CC1=C52)O)OCO4 | ||
| TCMBANKIN058634 | lycorine | AC-20268; CHEMBL583716; 2-epi-Lycorine; ZINC21992900; AKOS015965245; Licorine; NCI60_003767; UNII-I9Q105R5BU; ST24047513; Amarylline; HMS3402B04; QTL1_000052; AN-24834; HMS1989B04; 3,3a-Didehydrolycoran-1alpha,2beta-diol; NSC-683873; AN-50515; AJ-46629; AX8136904; KBio3_000043; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; MolPort-000-882-129; Galanthidine; Bio2_000022; KBioSS_000022; Lycorine hydrochloride; DTXSID60197208; NCGC00163413-02; EINECS 207-503-6; KBio2_005158; ZINC3881372; KBio2_000022; AC1L2HYJ; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; CHEBI:6601; SC-19266; CCG-208232; GNF-PF-4974; KBio3_000044; C08532; LS-88398; AC1Q6ZRB; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; MFCD00243111; Lycoran-1alpha,2beta-diol, 3,3a-didehydro- (8CI); SCHEMBL626071; NSC683873; Bio2_000502; (-)-Lycorine; CHEMBL400092; IDI1_033772; KBioGR_000022; KBio2_002590; BDBM50221066; HMS1361B04; NSC-401360; Likorin; MFCD00221746; NSC 401360; NCGC00163413-01; I9Q105R5BU; BSPBio_001302; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; lycorine; MCULE-4471227410; BRD-K64909280-001-02-7; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; 476-28-8; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1.alpha., 3,3a-didehydro-; BCBcMAP01_000100; NSC401360; HMS1791B04; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; ST085774; STOCK1N-67168; SMP1_000184; Narcissine; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)- (9CI); AK115153; 3,2.beta.-diol; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; AKOS000278045; (-)-lycorine; narcissine | C16H17NO4 | 287.31 g/mol | C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 |
| TCMBANKIN058650 | NarciPrimine | NareiPrimin | C14H9NO5 | 271.22 g/mol | C1OC2=C(O1)C(=C3C(=C2)C4=C(C(=CC=C4)O)NC3=O)O |
| TCMBANKIN058651 | lycoricidinol | narciclasine | C14H13NO7 | 307.25 g/mol | C1OC2=C(O1)C(=C3C(=C2)C4=CC(C(C(C4NC3=O)O)O)O)O |
| TCMBANKIN058837 | Supraene | trans-Squalene; SQUALENE; 94016-35-0; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-; (E,E,E,E)-Squalene; InChI=1/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24; 442785_SUPELCO; Squalene, Spinacene, Supraene; AIDS-017396; 2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; All-trans-Squalene; 111-02-4; EINECS 203-826-1; (14E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-,; S3626_SIGMA; 7683-64-9; CHEBI:15440; 2,6,10,14,18,22-tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (6E,10E,14E,18E)-; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene; AIDS017396; Spinacene; C00751; NSC93748; (all-E)-2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene; LMPR01060008; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (all-E)-; CCRIS 711; (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene;squalene | C30H50 | 410.72 | CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060957 | ELD | C18H35NO | 281.48g/mol | CCCCCCCCC=CCCCCCCCC(=O)N | |
| TCMBANKIN061028 | Myristamide;n-Tetradecanamide | C14H29NO | 227.39 | CCCCCCCCCCCCCC(=O)N | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061122 | tricosane | C23H48 | 324.63 g/mol | CCCCCCCCCCCCCCCCCCCCCCC | |
| TCMBANKIN061171 | Cetyl Iodide | C16H33I | 352.34 g/mol | CCCCCCCCCCCCCCCCI | |
| TCMBANKIN061257 | catalase | C9H10O3 | 166.17 g/mol | CCOC(=O)C1=CC=C(C=C1)O | |
| TCMBANKIN061294 | 1- methyl- 1H- pyrimidine- 2、4- dione | C5H6N2O2 | CN1C=CC(=O)NC1=O | ||
| TCMBANKIN061817 | 5-o-p-methoxy cinnamoyl scandoside methylester;E-6-O-p-methoxycinnamoyl scandoside methyl ester;6-o-z-p-methoxycinnamoyl scandoside methylester | AC1NSY1Y; 5-o-p-methoxy cinnamoyl scandoside methyl ester; methyl 7-(hydroxymethyl)-5-[(E)-3-(4-methoxyphenyl)prop-2-enoyl]oxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate | C27H32O13 | 550.51 | COC1=CC=C(C=C1)C=CC(=O)OC2C=C(C3C2C(=COC3OC4C(C(C(C(O4)CO)O)O)O)C(=O)OC)CO |
| TCMBANKIN000713 | Columbin | 546-97-4; Tinosporin; columbin; C09077 | C20H22O6 | 358.39 | CC12CCC3C(=O)OC(CC3(C1C4C=CC2(C(=O)O4)O)C)C5=COC=C5 |
| TCMBANKIN000962 | campesterol | campesterol ; FT-0082089; Augelicincampesterol; (24R)-5-Ergosten-3; (1R,3AS,3BR,9AS,9BS,11AR)-1-[(2R,5R)-5,6-DIMETHYLHEPTAN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,3BH,4H,5H,5AH,6H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; A-ol; 24(R)-Ergost-5-en-3beta-ol; 24alpha-Methyl-5-cholesten-3beta-ol; AK307302; SC-66911; (8R,9S,10S,13R,14S,17R)-17-((2R,5R)-5,6-Dimethylheptan-2-yl)-10,13-dimethyl-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; AKOS027320474; MFCD00010475; Campesterin; MolPort-035-882-175 | C28H48O | 400.68 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN000967 | bicyclo［10． 1． 0］trideca- 1-en | ||||
| TCMBANKIN001121 | latifoliumidrine | ||||
| TCMBANKIN001946 | 3- methyl- 1H- pyrimidine- 2,4- dione | 3-methyl-1H-pyrimidine-2,4-dione | C5H6N2O2 | 126.11 g/mol | CN1C(=O)C=CNC1=O |
| TCMBANKIN002220 | n-butyl-fructopyranoside | ||||
| TCMBANKIN003667 | crinumaquine | ||||
| TCMBANKIN004485 | lycorenan- 7-one | lycorenan-7-one | |||
| TCMBANKIN005404 | Hippeastrine | BPBio1_000847; STOCK1N-52692; BSPBio_000769; NSC731436; Lycorenan-7-one, 5-hydroxy-1-methyl-9,10-(methylenebis(oxy))-, (5alpha)-; 30803-79-3; hippeastrine; C08528; 477-17-8; Prestwick3_000675 | C17H17NO5 | 315.32 | CN1CCC2=CC(C3C(C21)C4=CC5=C(C=C4C(=O)O3)OCO5)O |
| TCMBANKIN005459 | γ-oryzanol | ||||
| TCMBANKIN006749 | crinasiadine | C14H9NO3 | 239.23 g/mol | C1OC2=C(O1)C=C3C(=C2)C4=CC=CC=C4NC3=O | |
| TCMBANKIN006763 | (2S)- 7,3＇- dihydroxy- 4＇- methoxyflavan | C16H16O4 | COC1=C(C=C(C=C1)C2CCC3=C(O2)C=C(C=C3)O)O | ||
| TCMBANKIN008153 | Nonadecanoic acid ethyl ester | C21H42O2 | 326.6 g/mol | CCCCCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN009041 | Ethyl oleate | 9-Octadecenoic acid (Z)-, ethyl ester; 9-Octadecenoic acid, (Z)-, ethyl ester; NSC 229428; 9-Octadecenoic acid, ethyl ester, (E)-; EINECS 203-889-5; Ethyl cis-9-octadecenoate; 9-OCTADECENOIC ACID ETHYL ESTER (Z); FEMA No. 2450; EINECS 228-082-5; octadec-9-enoic acid ethyl ester; Oleic acid, ethyl ester; 9-Octadecenoic acid (9Z)-, ethyl ester; Ethyl elaidate; ST5410316; ethyl (E)-octadec-9-enoate; (E)-octadec-9-enoic acid ethyl ester; ethyl oleate; 111-62-6; AI3-00657; 6114-18-7; Ethyl oleate (natural); Ethyl (9E)-9-octadecenoate; Elaidic acid ethyl ester; NSC229428; ethyl octadec-9-enoate; Ethyl 9-octadecenoate, (Z)-; (E)-9-Octadecenoic acid ethyl ester; E8377_SIGMA; 9-Octadecenoic acid, ethyl ester; Oleic acid, ethyl ester (6CI,8CI) | C20H38O2 | 310.51 | CCCCCCCCC=CCCCCCCCC(=O)OCC |
| TCMBANKIN009560 | lycoramine | C17H23NO3 | 289.37 | CN1CCC23CCC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br | |
| TCMBANKIN010138 | latiphenanthdrine | ||||
| TCMBANKIN011972 | sterylglucoside | C24H48O6 | CCCCCCCCCCCCCCCCCCOC1C(C(C(C(O1)CO)O)O)O | ||
| TCMBANKIN012433 | Pyrmidine-2,4- diol | Pyrmidine-2,4-diol | |||
| TCMBANKIN012509 | crinofolidine | C21H22N2O6 | COC(=O)C1C(CCC2C1C3(C(=O)C4=C(CCN3C2=O)C5=CC=CC=C5N4)O)O | ||
| TCMBANKIN013638 | lycorenine | C18H23NO4 | 317.4 g/mol | CN1CCC2=CCC3C(C21)C4=CC(=C(C=C4C(O3)O)OC)OC | |
| TCMBANKIN013900 | Arolyconricidine | ||||
| TCMBANKIN014354 | 6-hydroxy-eudesm-4(14)-ene | ||||
| TCMBANKIN014770 | 5-methyl-2-hexanonc | ||||
| TCMBANKIN014847 | Lycorenan | C15H17NO | 227.3 g/mol | C1CNC2C1=CCC3C2C4=CC=CC=C4CO3 | |
| TCMBANKIN015332 | lycorenium B | ||||
| TCMBANKIN016253 | 5＇-O-nitrosouridine | 5 ＇- O- nitrosouridine | |||
| TCMBANKIN016571 | Latifoliumdine | ||||
| TCMBANKIN016805 | cripowelline | ||||
| TCMBANKIN017221 | linoleic acid | (9E,12E)-octadeca-9,12-dienoate; AC1NYW3V; sodium (9E,12E)-octadeca-9,12-dienoate; BDBM22336; 9,12-octadecadienoate; linoleicacid | C18H31O2- | 279.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)[O-] |
| TCMBANKIN017351 | lycoridine | ||||
| TCMBANKIN017734 | latifoliumpurine | ||||
| TCMBANKIN017816 | tazettine | C18H21NO5 | 331.4 g/mol | CN1CC2(C3(C1CC(C=C3)OC)C4=CC5=C(C=C4CO2)OCO5)O | |
| TCMBANKIN018323 | Arolyeorieidin | ||||
| TCMBANKIN018400 | 1ycorenium A | C18H38I2N2O4 | C[N+](C)(C)CCOC(=O)CCCCCCC(=O)OCC[N+](C)(C)C.[I-].[I-] | ||
| TCMBANKIN019768 | Cinnamyl- D- glueopyranoside | Cinnamyl-D-glueopyranoside | |||
| TCMBANKIN019942 | vitamin e | vitamin-e; LS-187838; alpha-tocopherol; tocopherol; β-Tocopherol; α-tocopher | C29H50O2 | 430.7 g/mol | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C |
| TCMBANKIN020421 | Lyeorenan- 7- one | Lyeorenan-7-one | |||
| TCMBANKIN022904 | N- cis- coumaroyltyramine | ||||
| TCMBANKIN022973 | 5,10-diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-A.1',2'-D]pyrazine | C14H22N2O2 | CCOC1=C2CCCN2C(=C3N1CCC3)OCC | ||
| TCMBANKIN023444 | palmitic acid- 2-methylpropyl ester | ||||
| TCMBANKIN023447 | cristacarpin | C21H22O5 | 354.4 g/mol | CC(=CCC1=C(C=CC2=C1OC3C2(COC4=C3C=CC(=C4)O)O)OC)C | |
| TCMBANKIN023727 | pseudolycorine | C7H6O3 | 138.12 | COC1=C(C=C2C3C(C(C=C4C3N(CC4)CC2=C1)O)O)O | |
| TCMBANKIN024027 | 2,6,10-Trimethylundecan-2,9-dien-4-one | C14H24O | 208.34 g/mol | CC(CCC=C(C)C)CC(=O)C=C(C)C | |
| TCMBANKIN024989 | ergosta- 5- 3β-ol | ||||
| TCMBANKIN025194 | Tritetracontan | C43H86O | CCCCCCCCCCCCCCCCCCCCCC(=O)CCCCCCCCCCCCCCCCCCCCC | ||
| TCMBANKIN025300 | p- hydroxy- benzonicacid | p-hydroxy-benzonicacid | |||
| TCMBANKIN025333 | lyconrenan- 7- one | lyconrenan-7-one | |||
| TCMBANKIN025436 | N-Methyl- dendroblum | n-Methyl-dendroblum | |||
| TCMBANKIN025867 | Z- cinnalnie acid | Z-cinnalnieacid | |||
| TCMBANKIN025907 | crinasiatine | C22H17NO4 | 359.4 g/mol | C1C(OC2=C(O1)C=C3C4=CC=CC=C4NC(=O)C3=C2)CC5=CC=C(C=C5)O | |
| TCMBANKIN027604 | latifaliumin C | ||||
| TCMBANKIN028808 | latifoliumin A | C12H18O3 | CC(=O)C=CC1C2(CC(CC1(O2)C)O)C | ||
| TCMBANKIN030722 | Latifoliumprine | ||||
| TCMBANKIN031199 | latifoliumin B | ||||
| TCMBANKIN031266 | N- methyl- benzamide | N-methyl-benzamide | C8H9NO | 135.16 g/mol | CNC(=O)C1=CC=CC=C1 |
| TCMBANKIN032150 | stearic acid ethlyl ester | ||||
| TCMBANKIN032756 | latifoliumin D | ||||
| TCMBANKIN032837 | latifoliumside | ||||
| TCMBANKIN033166 | latifoliumol | C20H26O3 | CC1COC2=C1C=C3C=CC4C(CCCC4(CC3=C2O)O)(C)C | ||
| TCMBANKIN033515 | narcielasine | ||||
| TCMBANKIN033851 | pretazettine | C18H21NO5 | 331.4 g/mol | CN1CC2C3(C1CC(C=C3)OC)C4=CC5=C(C=C4C(O2)O)OCO5 | |
| TCMBANKIN034113 | Arolycorieidine | ||||
| TCMBANKIN035177 | Tetradecanamine | C14H31N | 213.4 g/mol | CCCCCCCCCCCCCCN | |
| TCMBANKIN035193 | N- palmitic acid | n-palmitic acid; n-Palmiticacid | |||
| TCMBANKIN036267 | 22-Tricosenoicacid | C23H44O2 | 352.6 g/mol | C=CCCCCCCCCCCCCCCCCCCCCC(=O)O | |
| TCMBANKIN037440 | Uridine | URI; SBB000838; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]pyrimidine-2,4-dione; SMR000058222; MLS000069625; AIDS185903; 1-beta-D-Ribofuranosyluracil; NSC 20256; 1-[(2R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-3H-PYRIMIDINE-2,4-DIONE; SY005419; AKOS015960347; MolPort-005-932-481; AC-10519; araU; 12693-39-9; ZINC02583633; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; AB0012293; Uracil-1-beta-D-ribofuranoside; SCHEMBL890304; NCGC00142368-01; C00299; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; BG00950366; U3750_SIGMA; Uridine, labeled with tritium; AI3-52690; AIDS-185903; U3003_SIGMA; AS-12665; Uracil, 1-beta-D-ribofuranosyl-; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl]pyrimidine-2,4-quinone; 21231-59-4; U6381_SIGMA; SMP1_000029; CHEBI:16704; 68184-15-6; 1-((2r,5r)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; EINECS 200-407-5 | 244.201 | ||
| TCMBANKIN043842 | Ungeremine | 266.27 g/mol | |||
| TCMBANKIN048621 | Ungermine | C16H12NO3 | C1(=C([H])C(=C2C(C(C([H])([H])C3([H])[H])=C([H])C(O[H])=C2[H])=N34)C5=C4[H])C(OC([H])([H])O1)=C5[H] | ||
| TCMBANKIN049078 | unicinatone | C20H22O4 | CC1CC2=C(C3=C(C(=C2O1)O)C4(CCC(=C(C4=CC3=O)C)C)C)O | ||
| TCMBANKIN058211 | p-aminobenzaldehyde | WLN: ZR DVH;Benzaldehyde, 4-amino-; BRN 1362885; 4-14-00-00048 (Beilstein Handbook Reference); ZINC01677280; 4-Aminobenzaldehyde; NSC60117; Benzaldehyde, p-amino- (8CI); p-Formylaniline; p-Aminobenzaldehyde; InChI=1/C7H7NO/c8-7-3-1-6(5-9)2-4-7/h1-5H,8H; 4-Formylaniline; NSC45163; Benzaldehyde, p-amino-; Benzaldehyde, 4-amino-, homopolymer; 556-18-3; 28107-09-7; NSC 45163; EINECS 209-115-2 | C7H7NO | 121.14 g/mol | C1=CC(=CC=C1C=O)N |
| TCMBANKIN058228 | 4',7-dihydroxyflavone | 4',7-dihydroxy-flavone | C15H10O4 | 254.24 | C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C=C(C=C3)O)O |
| TCMBANKIN058253 | trans-n-caffeoyltyramine | N- trans- caffeoyltyramine | C17H17NO4 | 299.32 g/mol | C1=CC(=CC=C1CCNC(=O)C=CC2=CC(=C(C=C2)O)O)O |
| TCMBANKIN058254 | N- trans- coumaroyltyramine | N-trans-coumaroyltyramine | C17H17NO3 | 283.32 g/mol | C1=CC(=CC=C1CCNC(=O)C=CC2=CC=C(C=C2)O)O |
| TCMBANKIN058306 | cinnamic acid | Cinnamic acid, (Z)-; trans-beta-Carboxystyrene; (Z)-3-phenylprop-2-enoate; Cinnamylic acid; trans-Zimtsaeure; Benzenepropenoic acid; Zimtsaeure; cinnamic acid ; 3-phenylprop-2-enoic acid; C80857_ALDRICH; 102-94-3; 133760_ALDRICH; AIDS-017619; tert-.beta.-Phenylacrylic acid; BRN 1905952; STK286093; InChI=1/C9H8O2/c10-9(11)7-6-8-4-2-1-3-5-8/h1-7H,(H,10,11; CCRIS 3190; NSC174025; 3-Phenylpropenoic acid; CHEBI:35700; W228818_ALDRICH; cinnamicacid; (E)-3-Phenyl-2-propenoic acid; 4-09-00-02002 (Beilstein Handbook Reference); NSC623441; AC1OAGPW; 140-10-3; Benzylideneacetic acid; NSC44010; Zimtsaeure [German]; 2-Propenoic acid, 3-phenyl-, (E)-; 3-Phenyl-2-propenoic acid; NSC9189; 2-Propenoic acid, 3-phenyl-, (Z)-; trans-3-Phenylacrylic acid; C10438; W228826_ALDRICH; Cinnamic acid, (E)-; WLN: QV1U1R; NCGC00165979-01; NSC 44010; CHEBI:27386; (2Z)-3-phenylacrylate; trans-Cinnamic acid; (Z)-Cinnamic acid; (2E)-3-phenylprop-2-enoic acid; Acidum cinnamylicum; (2E)-3-phenyl-2-propenoic acid; 621-82-9; cis-.beta.-Carboxystyrene; PHENYLETHYLENECARBOXYLIC ACID; EINECS 210-708-3; 2-Propenoic acid, 3-phenyl-; 3-Phenylacrylic acid; CHEBI:35697; EINECS 205-398-1; cis-Cinnamic acid; BRN 0507757; C00423; (2Z)-3-phenylprop-2-enoate; Kyselina skoricove [Czech]; Phenylacrylic acid; Cinnamic acid; Cinnamic acid (natural); (E)-3-phenylacrylic acid; cis-cinnamate; AI3-00891; (2E)-3-phenylacrylic acid; Allocinnamic acid; (E)-3-phenylprop-2-enoic acid; (E)-Cinnamic acid; beta-phenylacrylic acid; AIDS017619; trans-Cinnamate; trans-.beta.-Carboxystyrene; trans-3-Phenyl-2-propenoic acid; 96340_FLUKA; FEMA No. 2288; trans-3-Phenylpropensaeure; NSC 9189; Isocinnamic acid; AI3-23709; cis-Cinnamic acidanion; E-cinnamicacid; E-cinnamic acid; E- cinnamicacid; 3-Phenylpropenoic acid | C9H8O2 | 148.16 | C1=CC=C(C=C1)C=CC(=O)O |
| TCMBANKIN058358 | benzyl-D-glucopyranoside | benzyl- D- glucopyrano- side;4304-12-5; TimTec1_005150; Benzyl .beta.-D-glucopyranoside; AIDS-186169; benzyl glucopyranoside; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(phenylmethoxy)tetrahydropyran-3,4,5-triol; (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(phenylmethoxy)oxane-3,4,5-triol; AIDS186169; ACon1_002322; (2R,3R,4S,5S,6R)-2-(benzyloxy)-6-methylol-tetrahydropyran-3,4,5-triol;(2S,3S,4S,5S,6R)-2-(benzyloxy)-6-methylol-tetrahydropyran-3,4,5-triol; (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-(phenylmethoxy)tetrahydropyran-3,4,5-triol; ST5309395; B5782_SIGMA;Benzyl glucopyranoside;benzyl alcoholo-β-d-glucopyranoside;Benzyl alpha-D-mannopyranoside | C13H18O6 | 270.28 g/mol | C1=CC=C(C=C1)COC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN058450 | ADO | nchembio.2007.56-comp13; CHEBI:16335; Bio1_000437; 9-beta-D-Ribofuranosyl-9H-purin-6-amine; AIDS-001224; 9beta-D-Ribofuranosyladenine; BSPBio_001796; beta-Adenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methylol-tetrahydrofuran-3,4-diol; beta-D-Ribofuranoside, adenine-9; D00045; 46969-16-8; SDCCGMLS-0003108.P003; 4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; 6-Amino-9-.beta.-ribofuranosyl-9H-purine; NSC 7652; Bio1_001415; Adenosine (JAN/USP); Spectrum2_001257; Spectrum3_000288; Adenosine, homopolymer; ADN; Caswell No. 010B; Adenocard; C00212; SR 96225; Adenocard (TN); EINECS 200-389-9; KBio3_001296; 9H-Purin-6-amine, 9beta-D-ribofuranosyl-; Polyadenosine; beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-; (2R,3R,4S,5R)-2-(6-amino-9-purinyl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; MLS000069638; AI3-52413; 9-beta-D-Ribofuranosidoadenine; A9251_SIGMA; Adenoscan (TN); Bio1_000926; ZINC02169830; CCRIS 2557; NCGC00023673-05; Ade-Rib; nchembio706-5; 30143-02-3; 6-Amino-9-beta-D-ribofuranosyl-9H-purine; Adenosin [German]; NSC 627048; SMR000058216; 9-beta-D-Ribofuranosyladenine; SPBio_001194; beta-D-Adenosine; Adenosine [USAN:BAN]; Polyriboadenosine; (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; AIDS001224; 6-Amino-9beta-D-ribofuranosyl-9H-purine; ST009496; Adenoscan; A4036_SIGMA; SPECTRUM1500107; 46946-45-6;SCHEMBL170902; adenosine ; AKOS015960342; AC-5504; BC200893; Adenosine;adenosine;adeninenucleoside | C10H13N5O4 | 267.24 g/mol | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N |
| TCMBANKIN058549 | Lycorenium A | C16H12NO3+ | C1C[N+]2=CC3=CC4=C(C=C3C5=CC(=CC1=C52)O)OCO4 | ||
| TCMBANKIN058634 | lycorine | AC-20268; CHEMBL583716; 2-epi-Lycorine; ZINC21992900; AKOS015965245; Licorine; NCI60_003767; UNII-I9Q105R5BU; ST24047513; Amarylline; HMS3402B04; QTL1_000052; AN-24834; HMS1989B04; 3,3a-Didehydrolycoran-1alpha,2beta-diol; NSC-683873; AN-50515; AJ-46629; AX8136904; KBio3_000043; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; MolPort-000-882-129; Galanthidine; Bio2_000022; KBioSS_000022; Lycorine hydrochloride; DTXSID60197208; NCGC00163413-02; EINECS 207-503-6; KBio2_005158; ZINC3881372; KBio2_000022; AC1L2HYJ; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; CHEBI:6601; SC-19266; CCG-208232; GNF-PF-4974; KBio3_000044; C08532; LS-88398; AC1Q6ZRB; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; MFCD00243111; Lycoran-1alpha,2beta-diol, 3,3a-didehydro- (8CI); SCHEMBL626071; NSC683873; Bio2_000502; (-)-Lycorine; CHEMBL400092; IDI1_033772; KBioGR_000022; KBio2_002590; BDBM50221066; HMS1361B04; NSC-401360; Likorin; MFCD00221746; NSC 401360; NCGC00163413-01; I9Q105R5BU; BSPBio_001302; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; lycorine; MCULE-4471227410; BRD-K64909280-001-02-7; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; 476-28-8; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1.alpha., 3,3a-didehydro-; BCBcMAP01_000100; NSC401360; HMS1791B04; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; ST085774; STOCK1N-67168; SMP1_000184; Narcissine; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)- (9CI); AK115153; 3,2.beta.-diol; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; AKOS000278045; (-)-lycorine; narcissine | C16H17NO4 | 287.31 g/mol | C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 |
| TCMBANKIN058650 | NarciPrimine | NareiPrimin | C14H9NO5 | 271.22 g/mol | C1OC2=C(O1)C(=C3C(=C2)C4=C(C(=CC=C4)O)NC3=O)O |
| TCMBANKIN058651 | lycoricidinol | narciclasine | C14H13NO7 | 307.25 g/mol | C1OC2=C(O1)C(=C3C(=C2)C4=CC(C(C(C4NC3=O)O)O)O)O |
| TCMBANKIN058837 | Supraene | trans-Squalene; SQUALENE; 94016-35-0; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-; (E,E,E,E)-Squalene; InChI=1/C30H50/c1-25(2)15-11-19-29(7)23-13-21-27(5)17-9-10-18-28(6)22-14-24-30(8)20-12-16-26(3)4/h15-18,23-24H,9-14,19-22H2,1-8H3/b27-17+,28-18+,29-23+,30-24; 442785_SUPELCO; Squalene, Spinacene, Supraene; AIDS-017396; 2,6,10,15,19,23-Hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; All-trans-Squalene; 111-02-4; EINECS 203-826-1; (14E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-,; S3626_SIGMA; 7683-64-9; CHEBI:15440; 2,6,10,14,18,22-tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (6E,10E,14E,18E)-; 2,6,10,15,19,23-Hexamethyltetracosa-(2E,6E,10E,14E,18E,22E)-2,6,10,14,18,22-hexaene; AIDS017396; Spinacene; C00751; NSC93748; (all-E)-2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene; LMPR01060008; 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl-, (all-E)-; CCRIS 711; (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene;squalene | C30H50 | 410.72 | CC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN060706 | Linolenic acid ethyl ester | C20H34O2 | 306.48 | CCC=CCC=CCC=CCCCCCCCC(=O)OCC | |
| TCMBANKIN060957 | ELD | C18H35NO | 281.48g/mol | CCCCCCCCC=CCCCCCCCC(=O)N | |
| TCMBANKIN061071 | Ethylpalmitate | C18H36O2 | 284.5 g/mol | CCCCCCCCCCCCCCCC(=O)OCC | |
| TCMBANKIN061171 | Cetyl Iodide | C16H33I | 352.34 g/mol | CCCCCCCCCCCCCCCCI | |
| TCMBANKIN061257 | catalase | C9H10O3 | 166.17 g/mol | CCOC(=O)C1=CC=C(C=C1)O | |
| TCMBANKIN061294 | 1- methyl- 1H- pyrimidine- 2、4- dione | C5H6N2O2 | CN1C=CC(=O)NC1=O | ||
| TCMBANKIN061817 | 5-o-p-methoxy cinnamoyl scandoside methylester;E-6-O-p-methoxycinnamoyl scandoside methyl ester;6-o-z-p-methoxycinnamoyl scandoside methylester | AC1NSY1Y; 5-o-p-methoxy cinnamoyl scandoside methyl ester; methyl 7-(hydroxymethyl)-5-[(E)-3-(4-methoxyphenyl)prop-2-enoyl]oxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate | C27H32O13 | 550.51 | COC1=CC=C(C=C1)C=CC(=O)OC2C=C(C3C2C(=COC3OC4C(C(C(C(O4)CO)O)O)O)C(=O)OC)CO |
| TCMBANKIN061923 | crinamine | CHEMBL1221865; Crinamine; ZINC8652224; (+)-crinamine | C17H19NO4 | 301.34 g/mol | COC1CC2C3(C=C1)C(CN2CC4=CC5=C(C=C34)OCO5)O |
| TCMBANKIN041609 | Norgalanthamine | 273.33 g/mol | |||
| TCMBANKIN043837 | Criasiaticidine A | ||||
| TCMBANKIN046202 | Pratorimine | 265.26 g/mol | |||
| TCMBANKIN047254 | 4'-hydroxy-7-methoxyflavan-3-ol | C16H16O4 | COC1=CC2=C(CC(C(O2)C3=CC=C(C=C3)O)O)C=C1 | ||
| TCMBANKIN058634 | lycorine | AC-20268; CHEMBL583716; 2-epi-Lycorine; ZINC21992900; AKOS015965245; Licorine; NCI60_003767; UNII-I9Q105R5BU; ST24047513; Amarylline; HMS3402B04; QTL1_000052; AN-24834; HMS1989B04; 3,3a-Didehydrolycoran-1alpha,2beta-diol; NSC-683873; AN-50515; AJ-46629; AX8136904; KBio3_000043; 3,12-[methylenebis(oxy)]-galanthan-1.alpha.,2.beta.-diol; MolPort-000-882-129; Galanthidine; Bio2_000022; KBioSS_000022; Lycorine hydrochloride; DTXSID60197208; NCGC00163413-02; EINECS 207-503-6; KBio2_005158; ZINC3881372; KBio2_000022; AC1L2HYJ; 2,4,5,7,12b,12c-Hexahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol, (1S,2S,12bS, 12cS)-; CHEBI:6601; SC-19266; CCG-208232; GNF-PF-4974; KBio3_000044; C08532; LS-88398; AC1Q6ZRB; Lycoran-1-alpha,2-beta-diol, 3,3-alpha-didehydro-; MFCD00243111; Lycoran-1alpha,2beta-diol, 3,3a-didehydro- (8CI); SCHEMBL626071; NSC683873; Bio2_000502; (-)-Lycorine; CHEMBL400092; IDI1_033772; KBioGR_000022; KBio2_002590; BDBM50221066; HMS1361B04; NSC-401360; Likorin; MFCD00221746; NSC 401360; NCGC00163413-01; I9Q105R5BU; BSPBio_001302; 9,10-(methylenedioxy)-3,12-didehydrogalanthan-1alpha,2beta-diol; lycorine; MCULE-4471227410; BRD-K64909280-001-02-7; Galanthan-1, 3,4-didehydro-11,12-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1alpha,2beta-diol, 3,3a-didehydro-; 476-28-8; Galanthan-1, 3,12-didehydro-9,10-[methylenebis(oxy)]-, (1.alpha.,2.beta.)-; Lycoran-1.alpha., 3,3a-didehydro-; BCBcMAP01_000100; NSC401360; HMS1791B04; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)-; ST085774; STOCK1N-67168; SMP1_000184; Narcissine; Galanthan-1,2-diol, 3,12-didehydro-9,10-(methylenebis(oxy))-, (1-alpha,2-beta)- (9CI); AK115153; 3,2.beta.-diol; 2,5,7,12b,12c-Hexahydro-1H-[1,3]-dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol; AKOS000278045; (-)-lycorine; narcissine | C16H17NO4 | 287.31 g/mol | C1CN2CC3=CC4=C(C=C3C5C2C1=CC(C5O)O)OCO4 |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab